Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer - Contacts and Locations

Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer

This study is ongoing, but not recruiting participants.

Study NCT00072033. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00072033

Locations


Switzerland
	Centre Hospitalier Universitaire Vaudois
	Lausanne, Switzerland, CH-1011
	City Hospital Triemli
	Zurich, Switzerland, 8063
	Hopital Cantonal Universitaire de Geneve
	Geneva, Switzerland, CH-1211
	Inselspital Bern
	Bern, Switzerland, CH-3010
	Universitaetsspital-Basel
	Basel, Switzerland, CH-4031
	Kantonsspital - St. Gallen
	St. Gallen, Switzerland, CH-9007
	Ospedale Civico
	Lugano, Switzerland, CH-6900
	Spitaeler Chur AG
	Chur, Switzerland, CH-7000
	Kantonspital Aarau
	Aarau, Switzerland, CH-5001

Sponsors and Collaborators

Swiss Group for Clinical Cancer Research

Investigators


Study Chair:	Thomas Ruhstaller, MD	Kantonsspital - St. Gallen